Literature DB >> 8543789

Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene.

Z Song1, V Casolaro, R Chen, S N Georas, D Monos, S J Ono.   

Abstract

Atopy, which predisposes individuals to develop asthma, severe systemic anaphylaxis, and atopic dermatitis, is usually associated with dramatically elevated total serum IgE levels and is thought to be controlled by a major susceptibility gene and multiple minor susceptibility genes. A recent sib-pair analysis revealed a tight linkage between markers on 5q31.1 and a major susceptibility gene controlling total serum IgE levels. Due to its location within this cluster and its biologic role in Ig class switching and Th2 cell differentiation, the IL-4 gene has emerged as one major candidate for the atopy gene. In one model, polymorphisms within IL-4 regulatory elements might result in overexpression of the gene, amplifying Th2 cell differentiation and class switching to IgE. In support of this model, we report that the human IL-4 promoter exists in multiple allelic forms that exhibit distinct transcriptional activities in IL-4-positive T cells. A particular allele has an unusually high transcriptional activity. A nucleotide substitution within a recently described OAP40 element located just upstream of an NF-AT site (P sequence) appears to be largely responsible for the increased promotor strength of this particular allelic form of the IL-4 promoter. In EMSAs, this substitution results in a markedly enhanced affinity for sequence-specific complexes exhibiting an AP-1 specificity. The identification of allelic nucleotides, which results in overexpression of the IL-4 gene, provides specific targets for a comprehensive screening of atopic and nonatopic individuals and may provide a clue for genetic predisposition for atopy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8543789

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

Review 1.  [Rheumatology update. Current knowledge of etiology, pathophysiology, diagnosis, and therapy of selected arthritic disorders. Part I: pathogenesis and differential diagnosis].

Authors:  G Hein; P Oelzner; H Sprott; B Manger
Journal:  Med Klin (Munich)       Date:  1999-09-15

2.  Epithelial cells and atopic diseases.

Authors:  G Girolomoni; S Pastore
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

3.  HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Jenna E Ryan; Robert A Vierkant; V Shane Pankratz; Steven J Jacobsen; Gregory A Poland
Journal:  Immunogenetics       Date:  2005-01-27       Impact factor: 2.846

4.  Different cytokine profiles in patients with a history of gangrenous or phlegmonous appendicitis.

Authors:  M Rubér; A Berg; C Ekerfelt; G Olaison; R E Andersson
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

Review 5.  IL-4: role in disease and regulation of production.

Authors:  P Choi; H Reiser
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

Review 6.  Molecular immunopathogenesis of HIV infection.

Authors:  T T Ng; A J Pinching; C Guntermann; W J Morrow
Journal:  Genitourin Med       Date:  1996-12

7.  Identification of a large novel imprinted gene cluster on mouse proximal chromosome 6.

Authors:  Ryuichi Ono; Hirosuke Shiura; Hiroyuki Aburatani; Takashi Kohda; Tomoko Kaneko-Ishino; Fumitoshi Ishino
Journal:  Genome Res       Date:  2003-07       Impact factor: 9.043

8.  Polymorphisms of genes encoding interleukin-4 and its receptor in Iranian patients with juvenile idiopathic arthritis.

Authors:  Vahid Ziaee; Arezou Rezaei; Sara Harsini; Marzieh Maddah; Samaneh Zoghi; Maryam Sadr; Mohammad Hassan Moradinejad; Nima Rezaei
Journal:  Clin Rheumatol       Date:  2016-03-07       Impact factor: 2.980

9.  Role played by Th2 type cytokines in IgE mediated allergy and asthma.

Authors:  Sudha S Deo; Kejal J Mistry; Amol M Kakade; Pramod V Niphadkar
Journal:  Lung India       Date:  2010-04

10.  Functional analysis of -351 interleukin-9 promoter polymorphism reveals an activator controlled by NF-kappaB.

Authors:  S B Early; P Huyett; K Brown-Steinke; L Borish; J W Steinke
Journal:  Genes Immun       Date:  2009-04-23       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.